v3.24.1.u1
Restructuring Plans (Tables)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Allergan integration plan    
Restructuring charges    
Summary of charges associated with integration plan  
The following table summarizes the prior year charges associated with the Allergan acquisition integration plan:
Three months ended
March 31,
(in millions)2023
Cost of products sold$14 
Research and development— 
Selling, general and administrative44 
Total charges$58 
Other restructuring    
Restructuring charges    
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for the three months ended March 31, 2024:
(in millions)
Accrued balance as of December 31, 2023$196 
Restructuring charges14 
Payments and other adjustments(32)
Accrued balance as of March 31, 2024$178